Cargando…

Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia

Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Peng, Shi, Hai, Zhang, Yanjie, Zhou, Huabang, Dong, Jinhua, Cai, Yiting, Hu, Xing, Dai, Qiang, Yang, Wenyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617067/
https://www.ncbi.nlm.nih.gov/pubmed/26181569
http://dx.doi.org/10.1097/MD.0000000000001193
_version_ 1782396757492105216
author Cheng, Peng
Shi, Hai
Zhang, Yanjie
Zhou, Huabang
Dong, Jinhua
Cai, Yiting
Hu, Xing
Dai, Qiang
Yang, Wenyan
author_facet Cheng, Peng
Shi, Hai
Zhang, Yanjie
Zhou, Huabang
Dong, Jinhua
Cai, Yiting
Hu, Xing
Dai, Qiang
Yang, Wenyan
author_sort Cheng, Peng
collection PubMed
description Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeutic effect was achieved without serious complications. We report the therapeutic experience with pneumatic dilation, having aimed to evaluate the long-term clinical safety and efficacy of pneumatic dilation. In total, 35 consecutive patients with idiopathic achalasia who underwent pneumatic dilation were followed up at regular intervals in person or by a phone interview over a 10-year period. The mean duration of the follow-up was 43.03 ± 26.34 months (range 6–120 months). Remission was assessed by the dysphagia classification and symptom scores. Patients’ clinical symptom scores were calculated before and at 6 to 36 months, 37 to 60 months, and >60 months after therapy. The influence of the patients’ age, gender, and disease duration on the therapeutic effect was analyzed. The success rate of the operation was 97.2% (35/36), without massive hemorrhaging, perforation or other serious complications. Dysphagia after the therapy was significantly eased (P < 0.01). In total, 35 patients have been followed up for 6 to 36 months after therapy, 21 cases for 37 to 60 months, and 5 cases for >60 months, and the patients’ symptom scores separately decreased significantly compared with the pretherapy scores (P < 0.01). For these patients, the 6 to 36 months remission rate was 85.7% (30/35), the 37 to 60 months rate was 61.9% (13/21), and the >60 months rate was 40% (2/5). The dilation effect had no relationship to the patient's age, gender, and disease duration (P > 0.05). The patients in 30 cases (85.7%) were successfully treated with a single dilation, in 4 cases (11.4%) with 2 dilations, and in 1 case (2.9%) with 3 dilations. These results suggest that endoscopic pneumatic dilation is an achalasia therapy with a good response; it is a simple and safe procedure with long-term clinical effectiveness. It is a preferred method in the treatment of achalasia.
format Online
Article
Text
id pubmed-4617067
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-46170672015-10-27 Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia Cheng, Peng Shi, Hai Zhang, Yanjie Zhou, Huabang Dong, Jinhua Cai, Yiting Hu, Xing Dai, Qiang Yang, Wenyan Medicine (Baltimore) 4500 Although pneumatic dilation is an accepted method for the treatment of achalasia, this therapy has high recurrence and complication rates, and prolonged follow-up studies on the parameters associated with various outcomes are rare. In this prospective 10-year follow-up study, a satisfactory therapeutic effect was achieved without serious complications. We report the therapeutic experience with pneumatic dilation, having aimed to evaluate the long-term clinical safety and efficacy of pneumatic dilation. In total, 35 consecutive patients with idiopathic achalasia who underwent pneumatic dilation were followed up at regular intervals in person or by a phone interview over a 10-year period. The mean duration of the follow-up was 43.03 ± 26.34 months (range 6–120 months). Remission was assessed by the dysphagia classification and symptom scores. Patients’ clinical symptom scores were calculated before and at 6 to 36 months, 37 to 60 months, and >60 months after therapy. The influence of the patients’ age, gender, and disease duration on the therapeutic effect was analyzed. The success rate of the operation was 97.2% (35/36), without massive hemorrhaging, perforation or other serious complications. Dysphagia after the therapy was significantly eased (P < 0.01). In total, 35 patients have been followed up for 6 to 36 months after therapy, 21 cases for 37 to 60 months, and 5 cases for >60 months, and the patients’ symptom scores separately decreased significantly compared with the pretherapy scores (P < 0.01). For these patients, the 6 to 36 months remission rate was 85.7% (30/35), the 37 to 60 months rate was 61.9% (13/21), and the >60 months rate was 40% (2/5). The dilation effect had no relationship to the patient's age, gender, and disease duration (P > 0.05). The patients in 30 cases (85.7%) were successfully treated with a single dilation, in 4 cases (11.4%) with 2 dilations, and in 1 case (2.9%) with 3 dilations. These results suggest that endoscopic pneumatic dilation is an achalasia therapy with a good response; it is a simple and safe procedure with long-term clinical effectiveness. It is a preferred method in the treatment of achalasia. Wolters Kluwer Health 2015-07-17 /pmc/articles/PMC4617067/ /pubmed/26181569 http://dx.doi.org/10.1097/MD.0000000000001193 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0, where it is permissible to download, share and reproduce the work in any medium, provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle 4500
Cheng, Peng
Shi, Hai
Zhang, Yanjie
Zhou, Huabang
Dong, Jinhua
Cai, Yiting
Hu, Xing
Dai, Qiang
Yang, Wenyan
Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
title Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
title_full Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
title_fullStr Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
title_full_unstemmed Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
title_short Clinical Effect of Endoscopic Pneumatic Dilation for Achalasia
title_sort clinical effect of endoscopic pneumatic dilation for achalasia
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617067/
https://www.ncbi.nlm.nih.gov/pubmed/26181569
http://dx.doi.org/10.1097/MD.0000000000001193
work_keys_str_mv AT chengpeng clinicaleffectofendoscopicpneumaticdilationforachalasia
AT shihai clinicaleffectofendoscopicpneumaticdilationforachalasia
AT zhangyanjie clinicaleffectofendoscopicpneumaticdilationforachalasia
AT zhouhuabang clinicaleffectofendoscopicpneumaticdilationforachalasia
AT dongjinhua clinicaleffectofendoscopicpneumaticdilationforachalasia
AT caiyiting clinicaleffectofendoscopicpneumaticdilationforachalasia
AT huxing clinicaleffectofendoscopicpneumaticdilationforachalasia
AT daiqiang clinicaleffectofendoscopicpneumaticdilationforachalasia
AT yangwenyan clinicaleffectofendoscopicpneumaticdilationforachalasia